July 26, 2017 1:04 AM ET


Company Overview of UCB Pharma S.A.

Company Overview

UCB Pharma S.A., a biopharmaceutical company, engages in the research, development, manufacture, and marketing of products for central nervous system disorders and immunology. The company's primary products for central nervous system disorders comprise Keppra for the treatment of partial onset and myoclonic seizures; Neupro for parkinson's disease; Equasym XL/Metadate CD for treating attention deficit hyperactivity disorder; Nootropil for treating vertigo; and Vimpat for partial onset seizures. The company’s primary products for immunology include Zyrtec for seasonal allergic rhinitis, perennial allergic rhinitis, and chronic idiopathic urticaria; Xyzal, an antihistamine for the symptomatic ...

Paseo de la Castellana 141

Planta 15

Madrid,  28046



34 91 570 34 44


34 91 570 29 62

Key Executives for UCB Pharma S.A.

UCB Pharma S.A. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
Ability Pharmaceuticals, S.L. Europe
Activery Biotech SL Europe
Aelix Therapeutics SL Europe
AlbaJuna Therapeutics SL Europe
Alcaliber S.A. Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States
Bertelsmann AG Europe
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact UCB Pharma S.A., please visit www.ucbpharma.es. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.